APA (7th ed.) Citation

SJ, G., K, P., N, P., S, A., B, V., K, S., . . . PW, H. (2022). Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer. Molecular cancer therapeutics, 21(9), 1439. https://doi.org/10.1158/1535-7163.MCT-22-0145

Chicago Style (17th ed.) Citation

SJ, Gregson, et al. "Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer." Molecular Cancer Therapeutics 21, no. 9 (2022): 1439. https://doi.org/10.1158/1535-7163.MCT-22-0145.

MLA (9th ed.) Citation

SJ, Gregson, et al. "Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer." Molecular Cancer Therapeutics, vol. 21, no. 9, 2022, p. 1439, https://doi.org/10.1158/1535-7163.MCT-22-0145.